ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Efficacy and safety analysis of the zanubrutinib-based bridging regimen in chimeric antigen receptor T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma].

Y Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.